← Back to Search

COVID-19 mHealth Intervention for Coronavirus Pandemic (COVID-19 Trial)

N/A

Waitlist Available

Led By Jason Glenn, PHD

Research Sponsored by University of Kansas Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up year 2

Awards & highlights

COVID-19 Trial Summary

This trial aims to use mobile technology to increase COVID-19 testing & vaccine knowledge and access among women with complex healthcare needs.

Who is the study for?

This trial is for women involved with the criminal legal system who are already part of the Tri-City C.R.E.W. study. They must be able to understand and agree to participate in the research voluntarily.Check my eligibility

What is being tested?

The study aims to improve COVID-19 testing and vaccine knowledge, access, and use among these women using a mobile health (mHealth) approach tailored to their local needs.See study design

What are the potential side effects?

Since this trial focuses on education and literacy rather than medical treatments, there are no direct side effects from interventions like drugs or vaccines.

COVID-19 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ year 2

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~year 2

This trial's timeline: 3 weeks for screening, Varies for treatment, and year 2 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability and useability of COVID-19 testing and vaccine mHealth module

COVID-19 mistrust questions

COVID-19 testing

+4 more

COVID-19 Trial Design

1Treatment groups

Experimental Treatment

Group I: COVID-19 mHealth InterventionExperimental Treatment1 Intervention

We are using a pre-post study design, given the low risk of the educational intervention and expected benefit.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor

465 Previous Clinical Trials

168,791 Total Patients Enrolled

Jason Glenn, PHDPrincipal InvestigatorUniversity of Kansas School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being recruited to participate in this trial?

"Affirmative. Information posted on clinicaltrials.gov verifies that this medical investigation is actively enrolling patients. The trial was first published on June 15th 2022 and has since been updated to its most current iteration dated November 3rd 2022 with a target of 508 participants at 1 site."

Answered by AI

Is enrollment for this research project open at the present moment?

"This research undertaking is currently recruiting patients, with the initial posting on June 15th 2022 and most recent update occurring November 3rd of that same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement

Jason E Glenn, PhD 2022. "COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05582746.